Bring your Treatment Resistant Schizophrenia patients out of themselves

Welcome to Clozaril® Connect, a support programme to help clinicians diagnose, treat, and manage patients with Treatment Resistant Schizophrenia (TRS) who may benefit from clozapine – the only treatment recommended by the National Institute for Health and Care Excellence (NICE) for TRS.

Getting to know TRS

As part of the support offered by the Clozaril® Connect programme, this website provides healthcare professionals (HCPs) with a useful hub of information on all aspects of schizophrenia, with a special emphasis on those patients who fail to respond to initial treatments: TRS patients, and how Clozaril® (clozapine) can help these patients.

CLZ-2022-0108  May 2023

Restricted access

The website you are trying to access is designed for healthcare professionals only - the content is not designed for the general public.

Are you a healthcare professional based in UK or Ireland?


hcp popup title

Viatris Connect is an online platform for UK health Professionals.

Across the website you will find news, blogs and product information.

Register to Viatris Connect today

Please note that the website contains promotional and non-promotional material including educational content and resources to help you and your patients.